Drug Use Investigation for TYKERB Tablet (All Case Investigation)
Data on the safety and efficacy of TYKERB shall be collected from the patients in order to grasp the actual conditions of post-marketing use and assess background information on the patients.
Cancer
DRUG: Lapatinib
The incidence of adverse events in Japanese patients treated with TYKERB based on prescribing information under the conditions of general clinical practice, 1 year
Data on the safety and efficacy of TYKERB shall be collected from the patients in order to grasp the actual conditions of post-marketing use and assess background information on the patients.